NEU neuren pharmaceuticals limited

Ann: Q4 2021 quarterly activity and cash flow report, page-32

  1. 13,050 Posts.
    lightbulb Created with Sketch. 788
    aurel19672003: Thanks for a very excellent post !

    aurel19672003: "- a personal opinion, I may be wrong, is that FDA would approve an NDA submitted by a US pharma easier than submitted by a foreign minnow pharma company..."
    I FULLY AGREE with this comment - there must be a natural kind of "bias" in favour of the local heavyweights... Some of the FDA staff come from big US PHARMA companies were they worked before.
    This leads to your - in my view quite LOGICAL - conclusion about the best way forward for NNZ 2591:

    aurel19672003: "I would prefer NEU to partner with a BIG US PHARMA for P3 trial in US for NNZ 2591 rather than go it alone..."

    All the aforementioned purely JIMHO, of course!

    Once again: Many thanks, "aurel19672003" !

    wasa


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.280(2.28%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.52 $12.73 $12.26 $8.152M 652.1K

Buyers (Bids)

No. Vol. Price($)
1 665 $12.50
 

Sellers (Offers)

Price($) Vol. No.
$12.55 235 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.